Bugs without borders: Researchers track the emergence and global spread of healthcare associated Clostridium difficile

Researchers show that the global epidemic of Clostridium difficile 027/NAP1/BI in the early to mid-2000s was caused by the spread of two different but highly related strains of the bacterium rather than one as was previously thought. The spread and persistence of both epidemics were driven by the acquisition of resistance to a frontline antibiotic.

Unlike many other healthcare-associated bacteria, C. difficile produces highly resistant and infectious spores. These spores can promote the transmission of C. difficile and potentially facilitates its spread over greater geographical distances, even across continents.

This study highlights the ease and rapidity with which the hospital , C. difficile, can spread throughout the world, emphasising the of the global healthcare system.

"Between 2002 and 2006, we saw highly publicised outbreaks of C. difficile in hospitals across the UK, USA, Canada and Europe," says Dr Miao He, first author from the Wellcome Trust Sanger Institute. "We used advanced DNA sequencing to determine the of this epidemic and the subsequent pattern of global spread.

"We found that this outbreak came from two separate epidemic strains or lineages of C. difficile, FQR1 and FQR2, both emerging from North America over a very short period and rapidly spread between hospitals around the world."

The team used the genetic history to map both epidemic strains of C. difficile using a global collection of samples from hospital patients between 1985 and 2010. They demonstrated that the two C. difficile strains acquired resistance to this antibiotic, fluoroquinolone, separately, a key that may have instigated the epidemics in the early 2000s.

"Up until the early 2000s, fluoroquinolone was an effective treatment for C. difficile infection," says Professor Brendan Wren, author from the London School of Hygiene and Tropical Medicine. "We've seen that since these strains acquired resistance to this frontline antibiotic, not only is it now virtually useless against this organism, but resistance seems to have been a major factor in the continued evolution and persistence of these strains in hospitals and clinical settings."

The team found the first outbreak strain of C. difficile, FQR1 originated in the USA and spread across the country. They also saw sporadic cases of this strain of C. difficile in Switzerland and South Korea. They found that the second strain of C. difficile, FQR2, originated in Canada and spread rapidly over a much wider area, spreading throughout North America, Australia and Europe.

The team showed that the spread of C. difficile into the UK was frequently caused by long-range geographical transmission event and then spread extensively within the UK. They confirmed separate transmission events to Exeter, Ayrshire and Birmingham from North America and a transmission event from continental Europe to Maidstone. These events triggered large-scale C. difficile outbreaks in many hospitals across the UK in the mid-2000s.

"We have exposed the ease and rapidity with which these fluoroquinolone-resistant C. difficile have transmitted across the world," says Dr Trevor Lawley, lead author from the Wellcome Trust Sanger Institute. "Our research highlights how the global healthcare system is interconnected and how we all need to work together when an outbreak such as this occurs.

"Our study heralds a new era of forensic microbiology for the transmission tracking of this major global pathogen and will now help us understand at the genetic level how and why this pathogen has become so aggressive and transmissible worldwide. This research will act as a database for clinical researchers to track the genomic changes in C. difficile outbreaks."

More information: Nature Genetics doi:10.1038/ng.2478

Related Stories

C. difficile hypervirulence genes identified

Sep 25, 2009

Five genetic regions have been identified that are unique to the most virulent strain of Clostridium difficile (C. difficile), the hospital superbug. Researchers writing in BioMed Central's open access journal Genome Biolog ...

APIC launches first national C. difficile prevalence study

Mar 20, 2008

The Association for Professionals in Infection Control and Epidemiology (APIC) today announced a detailed strategy to combat Clostridium difficile-associated disease (CDAD). The initiative begins with the first national prevalence ...

C. difficile lengthens hospital stays by 6 days

Dec 05, 2011

A new study published in the CMAJ (Canadian Medical Association Journal) reports that hospital-acquired Clostridium difficile infection increases length of stay in hospital by an average of six days.

Recommended for you

Two genes linked to inflammatory bowel disease

19 hours ago

Inflammatory Bowel Disease (IBD), a group of chronic inflammatory disorders of the intestine that result in painful and debilitating complications, affects over 1.4 million people in the U.S., and while there are treatments ...

Low tolerance for pain? The reason may be in your genes

Apr 20, 2014

Researchers may have identified key genes linked to why some people have a higher tolerance for pain than others, according to a study released today that will be presented at the American Academy of Neurology's 66th Annual ...

User comments